Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019–2020? A cross-sectional study in ClinicalTrials.gov

por de Jong, Amos J, Grupstra, Renske J, Santa-Ana-Tellez, Yared, Zuidgeest, Mira G P, de Boer, Anthonius, Gardarsdottir, Helga
Publicado 2022

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective

por de Jong, Amos J., van Rijssel, Tessa I., Zuidgeest, Mira G. P., van Thiel, Ghislaine J. M. W., Askin, Scott, Fons‐Martínez, Jaime, De Smedt, Tim, de Boer, Anthonius, Santa‐Ana‐Tellez, Yared, Gardarsdottir, Helga
Publicado 2022

Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis

por Bigaeva, Emilia, Puerta Cavanzo, Nataly, Stribos, Elisabeth G. D., de Jong, Amos J., Biel, Carin, Mutsaers, Henricus A. M., Jensen, Michael S., Nørregaard, Rikke, Leliveld, Anna M., de Jong, Igle J., Hillebrands, Jan-Luuk, van Goor, Harry, Boersema, Miriam, Bank, Ruud A., Olinga, Peter
Publicado 2020